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Summary
In order to study mechanisms and regulation of RNA
polymerase II (RNAPII) ubiquitylation and degrada-
tion, highly purified factors were used to reconsti-
tute RNAPII ubiquitylation in vitro. We show that ar-
rested RNAPII elongation complexes are the preferred
substrates for ubiquitylation. Accordingly, not only
DNA-damage-dependent but also DNA-damage-inde-
pendent transcriptional arrest results in RNAPII ubiq-
uitylation in vivo. Def1, known to be required for
damage-induced degradation of RNAPII, stimulates
ubiquitylation of RNAPII only in an elongation com-
plex. Ubiquitylation of RNAPII is dependent on its
C-terminal repeat domain (CTD). Moreover, CTD phos-
phorylation at serine 5, a hallmark of the initiating
polymerase, but not at serine 2, a hallmark of the
elongating polymerase, completely inhibits ubiqui-
tylation. In agreement with this, ubiquitylated RNAPII
is hypophosphorylated at serine 5 in vivo, and muta-
tion of the serine 5 phosphatase SSU72 inhibits
RNAPII degradation. These results identify several
mechanisms that confine ubiquitylation of RNAPII to
the forms of the enzyme that arrest during elongation.
Introduction
RNAPII requires assistance from a plethora of tran-
scription factors not only to initiate from promoters but
also to perform efficient transcript elongation. It is evi-
dent from several lines of evidence that transcript elon-
gation by RNAPII involves frequent pausing and stall-
ing, and an important role of the many elongation
accessory factors may be to minimize the negative im-
pact of such events on transcription (Arndt and Kane,
2003).
But what happens when RNAPII becomes irreversibly*Correspondence: j.svejstrup@cancer.org.uk
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School of Life Science, Shandong University, Jinan 250100, Shan-
dong, China.arrested during transcription? Irreversible, or pro-
longed, arrest is likely to be a frequent occurrence, not
least in response to DNA damage (Svejstrup, 2002). Be-
cause RNAPII transcription is strand specific and does
not involve special lesion-bypass polymerases such as
those used for DNA replication, irreversible stalling/
arrest in an active gene can only be dealt with by repair-
ing the damage so that transcription can continue or by
somehow physically removing the stalled polymerase.
Evidence for both processes has been obtained (Svej-
strup, 2003).
Several types of DNA lesions in the transcribed
strand of active genes are removed much more quickly
than in the nontranscribed strand or in the genome
overall, via a process called transcription-coupled nu-
cleotide excision repair (TC-NER) (Bohr et al., 1985;
Svejstrup, 2002). The biochemical mechanisms un-
derlying TC-NER are still elusive but involve the stalled
polymerase and the transcription-repair coupling fac-
tors Cockayne’s syndrome (CS) A and CSB (Troelstra et
al., 1992; Henning et al., 1995; Svejstrup, 2002). CSB
belongs to the Swi2/Snf2 family of DNA-dependent
ATPases, and its functional homolog in the yeast
Saccharomyces cerevisiae is called Rad26 (van Gool et
al., 1994).
Evidence for ubiquitylation and proteasome-medi-
ated degradation of RNAPII in response to UV-gener-
ated DNA damage has also been obtained (Bregman et
al., 1996; Ratner et al., 1998; Beaudenon et al., 1999;
Luo et al., 2001). A functional connection between TC-
NER and RNAPII degradation was uncovered when it
was found that yeast Rad26 interacts with Def1, a pro-
tein required for ubiquitylation of RNAPII in response to
DNA damage but not for TC-NER (Woudstra et al.,
2002). Conversely, while Rad26 is required for normal
TC-NER, it is not necessary for RNAPII degradation. To-
gether, these data led to the suggestion that cells
contend with damage-stalled RNAPII by a two-pronged
approach. First, rapid repair of the lesion by Rad26-
mediated TC-NER is attempted. However, if this fails,
RNAPII is degraded via Def1-mediated ubiquitylation/
degradation, presumably allowing the damage to later
be dealt with via general genome repair (Woudstra et
al., 2002; Svejstrup, 2003). This sequence of events,
with ubiquitylation/degradation of RNAPII being the last
resort, was suggested based on experiments in yeast,
but data from mammalian systems are also consistent
with this scenario (Luo et al., 2001; Lee et al., 2002).
While an overall model has been suggested for the
mechanisms ensuring that irreversibly stalled RNAPII
does not persist for long enough to compromise cell
viability (Svejstrup, 2003), biochemical results to di-
rectly support it are few. Moreover, studies to elucidate
the specific mechanisms underlying RNAPII ubiquityla-
tion and degradation are absent or confusing. For ex-
ample, it is unclear if (and how) the ubiquitylation ma-
chinery is directed specifically toward arrested RNAPII
as proposed. If stalled/arrested RNAPII is indeed the
target for ubiquitylation/degradation, this raises the
question of how polymerases stalling at DNA lesions
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914during transcript elongation are distinguished from p
polymerases that are immobile at promoters or are in a
the discontinuous, early stages of transcript elongation g
(promoter clearance). One of the distinguishing features r
of the different forms of RNAPII during the transcription o
cycle is their phosphorylation state (on the C-terminal
repeat domain [CTD] of the Rpb1 subunit) (Svejstrup, R
2004). Thus, RNAPII entering promoters is hypophos-
phorylated; newly initiated (promoter-proximal) poly- P
merases are phosphorylated at serine 5 in the CTD re- t
peat, while RNAPIIs engaged in processive transcript e
elongation are predominantly phosphorylated at serine (
2 and not at serine 5. However, the way that phosphory- t
lation of RNAPII affects its ubiquitylation is still unclear. o
RNAPII is a target for ubiquitylation in HeLa nuclear t
extracts, and ubiquitylation in these extracts is in- u
creased under conditions that allow transcription or w
when the DNA template is damaged (Lee et al., 2002). t
However, whether these stimulatory effects are caused R
by arrested elongation complexes or indirect effects t
has not been addressed. Experiments addressing the R
effect of RNAPII phosphorylation on ubiquitylation are h
similarly open to doubt. On one hand, it was reported a
that the form of RNAPII whose level was diminished (
most quickly after UV irradiation was the hypophos- t
phorylated form (Ratner et al., 1998). On the other hand, U
experiments using kinase inhibitors of some degree of t
specificity were used as basis to suggest that CTD E
phosphorylation plays a positive role for RNAPII ubiqui-
tylation (Mitsui and Sharp, 1999; Luo et al., 2001). The t
correct interpretation of these experiments in complex c
biological systems is complicated by the fact that the j
apparent disappearance of hypophosphorylated RNAPII 2
after UV irradiation (Ratner et al., 1998) might be t
caused by CTD phosphorylation rather than ubiquityla- w
tion and degradation. Likewise, CTD phosphorylation is
u
required for transcription, and polymerase arrest during
7
transcription might be required for ubiquitylation, so
w
the proposed positive effect of CTD phosphorylation
t(Mitsui and Sharp, 1999; Luo et al., 2001) might also be
gindirect or potentially even misleading.
eThe importance of better understanding the connec-
ition between RNAPII ubiquitylation and the CTD is also
cunderscored by experiments performed with the con-
aserved ubiquitin ligase Rsp5, which mediates damage-
induced RNAPII ubiquitylation/degradation in yeast
t(Beaudenon et al., 1999). Rsp5 contains a WW domain,
ythrough which it interacts with RNAPII in vitro. This pro-
gtein-protein interaction seems to occur via the RNAPII
tCTD but does not require CTD phosphorylation (Hui-
ibregtse et al., 1997). However, the functional impor-
ttance for RNAPII ubiquitylation of this interaction has
Unot been tested, and its significance has been ques-
ttioned by the finding that numerous unrelated proteins
pcarrying a WW domain are also capable of binding the
2CTD in vitro (Gavva et al., 1997).
iIn order to facilitate a real understanding of RNAPII
1ubiquitylation at the basic biochemical level, we estab-
slished an in vitro assay, which reconstitutes the reaction
uusing highly purified, physiologically relevant factors.
RBy the use of this system and complementing in vivo
pexperiments, we present evidence that sheds light on
ithe importance of the RNAPII ternary complex, DNAdamage, and Def1, as well as the CTD and CTD phos-horylation, for RNAPII ubiquitylation. Our data provide
conceptual context in which to understand the tar-
eting of RNAPII for ubiquitylation and degradation in
esponse to not only arrest at DNA lesions but also
ther transcription-obstructing events.
esults
rotein ubiquitylation typically requires enzymes of
hree different functional types, E1 (ubiquitin-activating
nzyme), E2 (ubiquitin-conjugating enzyme), and E3
ubiquitin ligase) (Pickart, 2001). Previous work showed
hat Rsp5 is the E3 for damage-induced ubiquitylation
f budding yeast RNAPII (Beaudenon et al., 1999). As
here is only one known E1 (Uba1), the only remaining
nknown factor for the basic ubiquitylation reaction
as therefore the E2. We reconstituted RNAPII ubiqui-
ylation with recombinant ubiquitylation factors and
NAPII, testing a variety of human rE2s for their ability
o support the reaction. Only Ubc5c supported robust
NAPII ubiquitylation (Figure 1A). The yeast homolog of
uman Ubc5c, Ubc5, was therefore expressed, purified,
nd used with the other highly purified yeast factors
see Figure S1 in the Supplemental Data available with
his article online) in the subsequent experiments.
sing this defined system, it was first established that
he RNAPII ubiquitylation reaction indeed requires E1,
2, and E3 (Figure 1B).
To investigate whether the reconstituted ubiquityla-
ion reaction targeted a biologically relevant lysine ac-
eptor residue, RNAPII ubiquitylated in vitro was sub-
ected to mass spectrometric analysis (Winkler et al.,
002). Using this approach, we identified a singly pro-
onated peptide with a molecular mass of 1956.027 Da,
hich corresponds to GG from the C terminus of ubiq-
itin linked to KVLDVTKEAQANLLTAK (residues 689–
05) of Rpb1. This peptide contains Rpb1 lysine 695,
hich was previously identified as a target of ubiqui-
ylation in vivo as part of a proteomics approach to
enerally identify ubiquitylated proteins in yeast (Peng
t al., 2003). These data indicate that the reconstituted
n vitro assay indeed results in ubiquitylation of an ac-
eptor lysine previously identified as a target of the re-
ction in vivo.
The biological relevance of the in vitro assay was fur-
her investigated by performing in vivo experiments. In
east, Ubc4 and Ubc5 are encoded by very similar
enes (97% similar at the amino acid level) whose func-
ion is overlapping (Seufert and Jentsch, 1990). So, to
nvestigate if Ubc5 is also the E2 for RNAPII ubiquityla-
ion in vivo, wild-type cells and cells lacking UBC4,
BC5, or both were UV irradiated and compared for
heir ability to degrade RNAPII (Figure 1C). As observed
reviously (Beaudenon et al., 1999; Woudstra et al.,
002), Rpb1, but not tubulin, was temporarily degraded
n response to DNA damage (Figure 1C, compare lane
with lanes 2 and 3). Such degradation was also ob-
erved in ubc4 and ubc5 single mutants. In contrast,
bc4 ubc5 double mutant cells were unable to degrade
pb1 under the same conditions (Figure 1C). These ex-
eriments thus support the finding that Ubc5 (or Ubc4)
s the ubiquitin-conjugating enzyme involved in dam-
age-mediated degradation of RNAPII.
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arrested RNAPII is a particularly good substrate.Figure 1. A Fully Defined System for Studying RNAPII Ubiquitylation
with Biologically Relevant Factors
(A) RNAPII ubiquitylation reconstituted in vitro. Ubiquitylation prod-
ucts were uncovered by probing Western blots with anti-hexahis-
tidine antibodies. Note that the ubiquitin substrate, as well as Ubc6
and Ubc8, was therefore also detected.
(B) Effect of omitting E1 (Uba1), E2 (Ubc5), or E3 (Rsp5) on RNAPII
ubiquitylation in vitro. The bands indicated as ubiquitylated Rpb1
were absent when RNAPII was left out, and their identify was fur-
ther confirmed by reprobing with Rpb1-specific antibodies (data
not shown).
(C) The amount of RNAPII in wild-type (WT) and cells lacking Ubc4
(ubc4), Ubc5 (ubc5), or both (ubc4 ubc5) at different times after UV
irradiation was investigated by Western blotting, probing with anti-
Rpb1 antibodies (4H8, which recognizes both phosphorylated and
unphosphorylated Rpb1). Tubulin (Tub1) was used as loading
control.Ubiquitylation of Elongating RNAPII Is Much More
Efficient Than That of Free RNAPII
Having established a fully defined in vitro ubiquitylation
system with physiologically relevant factors, it was now
possible to address important questions regarding ba-
sic properties and regulation of the RNAPII ubiquityla-
tion reaction. We first investigated whether the incorpo-
ration of RNAPII into an elongation-competent ternary
complex with DNA and RNA affects the efficiency of
the ubiquitylation reaction. Ternary RNAPII/DNA/RNA
complexes were assembled from highly purified RNAPII
and DNA/RNA oligonucleotides (Kireeva et al., 2000), of
which one of the DNA oligonucleotides (the transcribed
strand) was biotin tagged so that ternary complexes
could be purified (Figure S2; see also Experimental Pro-
cedures for details). Purified ternary complexes were
then compared with free RNAPII in the ubiquitylation
assay (Figure 2A). Strikingly, RNAPII in a purified ternary
complex was a much better substrate for ubiquitylation
than the same polymerase in free form was (Figure 2B,
upper panel), with up to 25-fold more ubiquitylation ob-
served when ternary complexes were used as sub-
strate (Figure 2B, lower panel). Purification of RNAPII
after ubiquitylation further confirmed that it was indeed
the polymerase, rather than another protein in the reac-
tion mixture, which was modified (Figure S3). More sig-
nificantly, the stimulation of RNAPII ubiquitylation in the
elongation complex was not observed when the RNA
oligonucleotide was omitted so that active RNAPII was
only associated with DNA (the purified DNA-RNAPII
complex mimicking promoter bound RNAPII) (Figure
2C, compare lanes 2 and 3).
Ubiquitylation of RNAPII Arrested at a DNA Lesion
Interestingly, these data opened the possibility that it is
primarily the RNAPII ternary complex, rather than spe-
cifically the structure arising when RNAPII arrests at a
DNA lesion, that is recognized by the ubiquitylation ma-
chinery. To directly address this possibility, RNAPII ter-
nary complexes were formed with oligonucleotides of
which the transcribed strand did, or did not, contain a
transcription-obstructing DNA lesion in the active site
of RNAPII (Figure 3A). In one case, RNAPII was allowed
to transcribe 34 nucleotides before reaching the lesion
(or arresting, if CTP was omitted, on the undamaged con-
trol template). In a parallel set of experiments, knowledge
of the precise position of RNAPII arrest (data not
shown) allowed assembly from oligonucleotides of a
ternary complex directly at the transcription-blocking
DNA lesion or on the corresponding “undamaged” cod-
ing strand (Figure S2; see Experimental Procedures for
details). In both sets of experiments, when “damaged”
and “undamaged” ternary complexes were compared,
similar final levels of RNAPII ubiquitylation were invaria-
bly observed (data not shown). However, a time course
of the ubiquitylation reaction uncovered a preference
for damage-stalled RNAPII (Figure 3C, compare lanes
3 and 11).
These data support the idea that the ubiquitylation
machinery possesses an intrinsic ability to recognize














wFigure 2. Elongating RNAPII Is the Preferred Target for the Basic
Ubiquitylation Machinery
(A) Cartoon of the different RNAPII forms tested. See Figure S2A Dfor details.
o(B) A comparison of free RNAPII and RNAPII in a ternary complex
Has substrates in reconstituted ubiquitylation reactions. Ubiquityla-
tion products were uncovered by probing Western blots with anti- a
hexahistidine antibodies. The reaction with free RNAPII contained g
300 ng RNAPII. The amounts of ternary complex tested were 30, D
60, 120, and 240 ng, respectively. The Rpb3 blot serves as a load-
oing control. The graph in the lower panel shows a quantification of
rthe results shown above (“total Rpb1 ubiquitylation to Rpb3” ratio;
eratio for free RNAPII was set to 1).
(C) Comparison of RNAPII in a ternary complex and DNA bound i
RNAPII as substrates in the reconstituted ubiquitylation reaction. p
oigure 3. The Effect of DNA Damage and Def1 on the Efficiency of
NAPII Ubiquitylation
A) Cartoon of the different RNAPII forms tested. Asterisk repre-
ents an AAF-mediated transcription-blocking lesion in the RNAPII
ctive site.
B) Effect of Def1 on ubiquitylation of free RNAPII in the reconstitu-
ed ubiquitylation reaction.
C) Ternary complexes assembled from oligonucleotides at a DNA
esion (DNA damage) or at the same position on undamaged con-
rol templates (No damage) were compared in reconstituted ubiqui-
ylation reactions in the presence or absence of Def1 as indicated.
biquitylation products were uncovered by probing Western blots
ith anti-hexahistidine antibodies.ef1 Preferentially Stimulates Ubiquitylation
f RNAPII in a Ternary Complex
aving established that RNAPII in a ternary complex is
n excellent target for ubiquitylation, we now investi-
ated the effect of the Def1 protein. Def1 is required for
NA-damage-induced ubiquitylation and degradation
f RNAPII in vivo (Woudstra et al., 2002), and recent
esults using an assay based on crude yeast cell-free
xtracts showed that it is also involved in ubiquitylation
n vitro (Reid and Svejstrup, 2004). Interestingly, in the
urified system, Def1 failed to elicit a positive effect
n ubiquitylation of free RNAPII but rather appeared tosomewhat inhibit the reaction (Figure 3B and data not
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a ternary complex, Def1 clearly stimulated the ubiqui-
tylation reaction, significantly increasing the rate of
modification (Figure 3C, compare lanes 2 and 3 with 6
and 7). A stimulatory effect of Def1 on ubiquitylation in
the presence of DNA damage was much less pro-
nounced but still detectable (compare lanes 10 and 14).
These data support the idea that Def1 contributes
directly to the preferential degradation of RNAPII stalled/
arrested during transcript elongation by increasing the
rate of its ubiquitylation.
Damage-Independent Transcription Arrest Also
Results in RNAPII Ubiquitylation In Vivo
Genetic data indicate that Def1 plays a role in transcript
elongation also in the absence of DNA damage (Woud-
stra et al., 2002), and the data presented above support
the idea that transcriptional arrest in general provides
a strong signal for RNAPII ubiquitylation. Therefore, we
tested whether DNA-damage-independent transcrip-
tional arrest can also lead to RNAPII ubiquitylation in
living cells. For this purpose, the effect of the elonga-
tion inhibitor 6-azaurazil (6-AU) on RNAPII ubiquityla-
tion was tested (6-AU causes a decrease in cellular
UTP/GTP levels). RNAPII was immunoprecipitated from
sonicated yeast extracts, and the ubiquitylation state
of Rpb1 was then tested by Western blotting, probing
with anti-ubiquitin antibodies (Figure 4). Treatment with
6-AU clearly induced RNAPII ubiquitylation (compare
lanes 1 and 2). Significantly, compromising transcript
elongation by deletion of DST1 (encoding TFIIS, in
whose absence the ability of RNAPII to escape arrest
is significantly impaired) in itself resulted in detectable
RNAPII ubiquitylation and also led to a further marked
increase in Rpb1 ubiquitylation levels in the presence
of 6-AU (compare lanes 2 and 4, and refer to loadingFigure 4. Transcriptional Arrest Results in RNAPII Ubiquitylation In
Vivo
Upper panel: Western blot of RNAPII immunoprecipitations from
extracts of the indicated cell types treated (+) or not treated (−) with
6-azauracil, probed with anti-ubiquitin antibodies. Lower panel:
Ponceau S stain of the membrane used for the Western blot. Note
that although less total Rpb1 was detected in the experiment repre-
senting dst1 cells treated with 6-AU (lane 4), more ubiquitylation
was detected. Lower Rpb1 levels are consistently observed in dst1
cells in the presence of 6-AU and may reflect significant RNAPII
degradation (C. Gilbert and J.Q.S., unpublished data).control shown in the lower panel). In strong support ofthe idea that the same factors are responsible for dam-
age-induced and damage-independent ubiquitylation,
RNAPII modification was dramatically reduced in ubc4
ubc5 double mutant cells (Figure 4, lanes 5 and 6).
Taken together, these data support the idea that tran-
scriptional arrest provoked by damage-independent
events also elicits RNAPII ubiquitylation.
RNAPII Ubiquitylation Requires the CTD
We next used the in vitro ubiquitylation system to in-
vestigate the functional importance of the RNAPII CTD
for ubiquitylation. For these experiments, we took ad-
vantage of a yeast strain expressing a modified form of
Rpb1 as the only source of this subunit (Feaver et al.,
1991). This form has a recognition site for FXa protease
engineered in between the body of the Rpb1 protein
and its highly flexible CTD repeats. We purified RNAPII
to virtual homogeneity from this strain by adsorbing it
to CTD binding 8WG16 antibodies immobilized on
Sepharose beads. After treatment of the bead bound
material with FXa protease, only CTD-less RNAPII was
released. As expected (Feaver et al., 1991), the mobility
of the Rpb1CTD subunit was increased compared to
normal Rpb1, while that of other subunits was un-
changed (Figure 5A and data not shown). Strikingly,
when similar amounts of the two RNAPII forms were
compared in the reconstitution assay, only wild-type
RNAPII was ubiquitylated (Figure 5B). Incorporation of
the CTD-less polymerase into a ternary complex (Fig-Figure 5. The RNAPII CTD Is Absolutely Required for Ubiquitylation
(A) Silver-stained gel depicting the two largest subunits of RNAPII
from wild-type and CTD-less RNAPII.
(B) Ubiquitylation of wild-type and CTD-less RNAPII.
(C) Ubiquitylation of wild-type and CTD-less RNAPII in a ternary
complex. Ubiquitylation products were uncovered by probing
Western blots with anti-hexahistidine antibodies.ure 5C) or addition of a large excess of ubiquitylation
Cell
918enzymes (data not shown) both failed to overcome the t
minhibition of the ubiquitylation reaction observed upon
CTD removal. i
aTaken together, these data demonstrate that the CTD
is absolutely required for RNAPII ubiquitylation. 3
b
3Serine 5 CTD Phosphorylation Inhibits RNAPII
Ubiquitylation
sThe CTD is reversibly modified by serine phosphoryla-
tion at positions 2 and 5 during the transcription cycle
(Svejstrup, 2004). We examined the effect of CTD phos- C
Rphorylation on RNAPII ubiquitylation. TFIIK and CTDK1
were purified to near homogeneity (see Figure S4) and P
pused in phosphorylation reactions with RNAPII. TFIIK
almost exclusively phosphorylates serine 5, while p
tCTDK1 predominantly phosphorylates serine 2 (Trigon
et al., 1998; Jones et al., 2004; data not shown). As 2
cexpected, treatment with these kinases yielded more-
slowly migrating Rpb1 forms because of CTD hyper- i
Sphosphorylation (Figure 6A, compare lane 1 with lanes
2 and 3). When these different RNAPII forms were sub- t
Fjected to ubiquitylation in vitro, TFIIK (serine 5) phos-
phorylation was completely inhibitory, while CTDK1 AFigure 6. CTD Serine 5 Phosphorylation Is Strongly Inhibitory to RNAPII Ubiquitylation
(A) Silver-stained gel depicting the two largest subunits of RNAPII before and after phosphorylation with highly purified TFIIK (Ser5) and
CTDK1 (Ser2) kinase, respectively.
(B) Ubiquitylation of unphosphorylated and the indicated phosphorylated forms of RNAPII.
(C) Ubiquitylation of CTD serine 2-phosphorylated RNAPII in a ternary complex.
(D) Ubiquitylation of CTD serine 5-phosphorylated RNAPII in a ternary complex.
(E) Silver-stained SDS-PAGE gel showing the migration of Rpb1 after Ssu72 treatment of serine 2- or serine 5-phosphorylated RNAPII.
(F) Effect of Ssu72-mediated serine 5 dephosphorylation on RNAPII ubiquitylation. Ubiquitylation products were uncovered by probing West-
ern blots with anti-hexahistidine antibodies.(serine 2) phosphorylation somewhat reduced ubiqui-ylation (Figure 6B). Significantly, incorporating the poly-
erase into a ternary complex significantly relieved the
nhibition imposed by serine 2 phosphorylation (to
bout 70%; Figure 6C, compare lane 2 with lanes 1 and
), but it did not relieve the complete inhibition imposed
y serine 5 phosphorylation (Figure 6D, compare lanes
and 4).
These results indicate that serine 5 phosphorylation
trongly negatively regulates RNAPII ubiquitylation.
TD Serine 5 Dephosphorylation by Ssu72 Restores
NAPII Ubiquitylation In Vitro
revious work established that Ssu72 phosphatase de-
hosphorylates CTD serine 5, while Fcp1 phosphatase
rimarily dephosphorylates serine 2 during transcrip-
ion in vivo (Cho et al., 2001; Krishnamurthy et al.,
004). If serine 5 phosphorylation were indeed the
ausative factor inhibiting RNAPII ubiquitylation, then
ncubation of the phosphorylated polymerase with
su72 would be expected to restore RNAPII ubiquityla-
ion. We purified GST-Ssu72 to virtual homogeneity (see
igure S4) and used it in RNAPII ubiquitylation assays.
s expected (Krishnamurthy et al., 2004), Ssu72 effi-ciently dephosphorylated serine 5-phosphorylated
Regulation of RNA Polymerases II Ubiquitylation
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observed with serine 2-phosphorylated RNAPII (Figure
6E, lanes 3 and 4, respectively). Importantly, Ssu72
treatment of serine 5-phosphorylated RNAPII com-
pletely restored the ability of the polymerase to act as
a substrate in the ubiquitylation reaction (Figure 6F,
compare lane 2 with lanes 1 and 3).
These data indicate that Ssu72-mediated CTD de-
phosphorylation is required for ubiquitylation of serine
5-phosphorylated RNAPII in vitro.
CTD Serine 5 Dephosphorylation by Ssu72
Is Required for Damage-Induced
RNAPII Degradation In Vivo
The role of CTD phosphorylation in regulating RNAPII
ubiquitylation was finally studied in vivo. The function
of the essential CTD phosphatases Ssu72 and Fcp1
can be abrogated in living cells by employing strains
carrying temperature-sensitive alleles of the respective
genes (Kobor et al., 1999; Krishnamurthy et al., 2004).
We UV irradiated such strains and their wild-type coun-
terparts after incubation at the restrictive temperature
(Figure 7). Cells lacking Fcp1 function (serine 2 dephos-
phorylation) degraded Rpb1 with kinetics that was in-
distinguishable from wild-type (Figure 7A, upper panel).
In contrast, a significant amount of Rpb1 (w40%) re-
mained stable in cells lacking Ssu72 function (lower
panel), suggesting that RNAPII ubiquitylation and deg-
radation were inhibited in the absence of efficient ser-Figure 7. CTD Serine 5 Hyperphosphorylation Inhibits RNAPII Ubiq-
uitylation In Vivo
(A) UV-induced degradation of Rpb1 in the indicated strains was
detected by Western blotting, probing with anti-Rpb1 antibodies
(4H8). Tubulin (Tub1) was used as loading control.
(B) Ubiquitylated proteins were isolated from a strain expressing
myc-tagged ubiquitin by 9E10 (anti-myc) immunoprecipitation. The
phosphorylation state of Rpb1 in the crude extract (extract) and
in the ubiquitin precipitates (ubi-IP) was investigated by Western
blotting of the same samples, probing with either CTD serine 5
(H14) or CTD serine 2 (H5) specific antibodies as indicated.ine 5 dephosphorylation.To further complement the in vitro experiments with
data from living cells, wild-type cells expressing a myc-
tagged version of ubiquitin as their only source of this
protein (Spence et al., 2000) were UV irradiated. Ubiqui-
tylated proteins, including RNAPII, were then isolated
from sonicated extracts from these cells by immuno-
precipitation with anti-myc antibodies. The phosphory-
lation status of RNAPII in the ubiquitin precipitates was
investigated by the use of antibodies specific for serine
2- and serine 5-phosphorylated RNAPII, respectively.
As can be seen in Figure 7B, significant amounts of
serine 2-phosphorylated, ubiquitylated Rpb1 was de-
tected, whereas, by comparison, only little serine 5
phosphorylation was observed on these ubiquitylated
forms of RNAPII (compare lanes 4–6 with lanes 10–12).
Taken together, these results support the idea that
serine 5 hypophosphorylation is also a prerequisite for
RNAPII ubiquitylation in vivo.
Discussion
Rpb1, the largest subunit of RNAPII, is ubiquitylated
and degraded in response to DNA damage, but the mo-
lecular mechanism underlying this highly conserved
process has so far been unclear. The results presented
here indicate that it is persistent stalling/arrest of the
elongating polymerase that triggers its ubiquitylation.
Using a reconstituted ubiquitylation system, we thus
found that incorporating RNAPII into an elongation
complex dramatically stimulates the activity of the ba-
sic RNAPII ubiquitylation machinery, while stalling at a
DNA lesion increases the ubiquitylation efficiency even
further. Additional specific stimulation of RNAPII ubiq-
uitylation in a ternary complex is brought about by
Def1, previously shown to be required for RNAPII ubiq-
uitylation and degradation in vivo. Importantly, evi-
dence from in vivo experiments supports the idea that
transcriptional arrest also results in polymerase ubiqui-
tylation in the absence of DNA damage. Our data also
show that the ubiquitylation machinery requires the
RNAPII CTD for correct targeting and that the phos-
phorylation state of the CTD is crucial for the efficiency
of the process, both in vitro and in vivo. Together, the
data thus identify a number of distinct and overlapping
mechanisms that regulate (or restrict) RNAPII ubiqui-
tylation.
A Reconstituted System for Studying RNAPII
Ubiquitylation with Physiologically
Relevant Factors In Vitro
Previous work established that Rsp5 is the ubiquitin li-
gase (E3) for yeast RNAPII ubiquitylation (Huibregtse et
al., 1997; Beaudenon et al., 1999). Our reconstitution of
RNAPII ubiquitylation with highly purified recombinant
factors indicates that the corresponding ubiquitin-con-
jugating enzyme (E2) is Ubc5 (or the functionally related
Ubc4 protein). The physiological relevance of this find-
ing is underscored by the finding that cells lacking both
UBC4 and UBC5 are unable to degrade RNAPII in
response to DNA damage. The establishment of a bio-
logically relevant, minimal system for RNAPII ubiqui-
tylation now allows future studies of a number of unre-
Cell
920solved questions about the mechanism and effect of e
2this polymerase modification.
d
oPreferential Recognition of the RNAPII/DNA/RNA
tTernary Complex by the Basic
iUbiquitylation Machinery
mRNAPII undergoes significant structural changes upon
lincorporation into a ternary RNAPII/DNA/RNA complex
p(Gnatt et al., 2001), and we found that the ternary com-
iplex is a strongly preferred target for ubiquitylation in
svitro. In contrast, RNAPII bound to double-stranded
dDNA (thus mimicking the promoter-associated form) is
lnot a preferred substrate. Based on these results, we
gsuggest that structural changes in RNAPII serve to des-
pignate the elongating form for preferential recognition
aby the basic ubiquitylation machinery. We also found
cthat the presence of a DNA damage to block the pro-
ugression of the polymerase results in an additional en-
hancement of ubiquitylation beyond that observed with
iternary complexes. Similar stimulation of RNAPII ubiq-
Ruitylation was observed upon addition of Def1. Genetic
ievidence indicates that DEF1 also affects transcription
pin the absence of DNA damage (Woudstra et al., 2002),
tand the results reported here indicate that the Def1 pro-
dtein works, at least partly, by enhancing the rate of
iRNAPII ubiquitylation in arrested elongation com-
tplexes.
pInterestingly, the region of RNAPII encompassing the
smapped ubiquitylation site at Rpb1 lysine 695 is not
ubelieved to undergo dramatic structural rearrangement
bupon ternary-complex formation (Gnatt et al., 2001).
mTherefore, the “binding site(s)” on RNAPII for the ubiq-
duitylation factors and the actual site(s) of modification
umay well be distinct. The previous observation that
aRsp5 binds the CTD (Huibregtse et al., 1997) and our
tfinding that the CTD is absolutely required for RNAPII
ubiquitylation nicely support this idea. Although struc-
Rturally unordered, the mobility and relative orientation
cof the CTD might change upon incorporation into a ter-
enary RNAPII elongation complex, facilitating the modifi-
qcation of Rpb1 lysine 695. Alternatively, other regions
hof the polymerase may also play a role in substrate re-
pcognition by the ubiquitylation factors. Interestingly, ly-
isine 695 is found in a region of Rpb1, which interacts
uwith Rpb9 (Cramer et al., 2001). The Rpb9 subunit of
ARNAPII is known to play a role in transcript elongation,
aparticularly during transcription through arrest sites
(Awrey et al., 1997). The effect of ubiquitylation on tran-
scription through such sites is an interesting and impor- D
tant topic for future investigation. Further biochemical o
details of the RNAPII ubiquitylation reaction await eluci- T
dation by structural analysis. t
d
DA Model for the Regulation of RNAPII Ubiquitylation
The phosphorylation state of the RNAPII CTD is known u
tto change significantly during the transcription cycle
(Svejstrup, 2004). The form of RNAPII entering an initia- g
otion complex is hypophosphorylated, but during tran-
scriptional initiation, the CTD becomes hyperphosphor- c
bylated at serine 5. This form of polymerase is thus
responsible for the first discontinuous transcription T
tevents occurring close to the promoter, prior to entryinto efficient, processive transcription. Polymerasesngaged in processive elongation are typified by serine
hyperphosphorylation (Komarnitsky et al., 2000). Our
ata show that the CTD phosphorylation state is of piv-
tal importance for the regulation of RNAPII ubiquityla-
ion. Thus, serine 5 hyperphosphorylation is completely
nhibitory for ubiquitylation in vitro, even when the poly-
erase is integrated into a ternary complex. The bio-
ogical relevance of this finding is underscored by ex-
eriments performed in vivo. Here it was found that
nactivating the serine 5-specific phosphatase Ssu72
ignificantly decreases damage-induced RNAPII degra-
ation. Moreover, ubiquitylated RNAPII isolated from
iving cells is severely serine 5 hypophosphorylated. To-
ether, these data strongly indicate that serine 5 hyper-
hosphorylation is inhibitory to RNAPII ubiquitylation
nd, together with the data on the effect of ternary-
omplex formation, support an attractive model for reg-
lation of RNAPII ubiquitylation/degradation (Figure S5).
According to this model, the ubiquitylation machinery
s targeted via specific recognition of the RNAPII/DNA/
NA ternary (elongation) complex. Soluble RNAPII and
mmobile polymerases that are found in initiation com-
lexes at the promoter are thus not targeted. Likewise,
he otherwise vulnerable polymerases that are in the
iscontinuous, early phases of transcription (which likely
nvolves extensive pausing/arrest/stalling) are pro-
ected from ubiquitylation/degradation by CTD serine 5
hosphorylation. This leaves serine 2-marked, proces-
ively transcribing RNAPII as the primary target for
biquitylation. Although other possibilities cannot yet
e ruled out, we speculate that such elongating poly-
erases only become good targets for ubiquitylation
uring transcriptional arrest/stalling because the ubiq-
itylation machinery (and Def1) cannot efficiently bind
nd modify the polymerase unless the DNA (or RNA) in
he ternary complex is immobile.
We assume that at least the basic properties of the
NAPII ubiquitylation process and its regulation are
onserved from yeast to man, but this remains an inter-
sting issue for future investigation. The factors re-
uired for RNAPII ubiquitylation and degradation in vivo
ave not yet been established in human cells, but the
ossibility that RNAPII ubiquitylation and degradation
n higher eukaryotes involve a recently isolated ubiq-
itin ligase complex containing Cockayne’s syndrome




he data presented here also underscore the impor-
ance of not simply regarding RNAPII ubiquitylation and
egradation as events that are specifically coupled to
NA repair and the damage response. Rather, RNAPII
biquitylation is likely to be a frequent event during
ranscription and also in the absence of DNA damage,
enerally serving as “a last resort” that increases the
verall efficiency of transcription by allowing the pro-
essing and eventual removal of arrested polymerases
y proteasome-mediated degradation (Svejstrup, 2003).
his idea is further supported by the recent finding that
he 26S proteasome is present in the coding region ofgenes during active transcription (Gillette et al., 2004).
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have a role in transcription independently of the protea-
some. Thus, the 19S regulatory subunit of the protea-
some has previously been shown to play a role in tran-
scription in the absence of proteolysis (Ferdous et al.,
2001) and is known to recognize its target proteins via
their ubiquitylation (Pickart, 2000). The precise molecu-
lar role of the 19S complex in transcript elongation is
unknown, but its recruitment almost certainly involves
RNAPII ubiquitylation.
Experimental Procedures
Yeast Strains and Plasmids
All Saccharomyces cerevisiae strains used in this study were grown
and manipulated using standard techniques (Sherman, 1991). Yeast
strains (sources) were: ubc4 ubc5 (Stefan Jentsch, Max Planck,
Martinsried, Germany), SUB592 (myc/his-tagged version of ubiq-
uitin) (Daniel Finley, Harvard Medical School), ssu72-td (Mike Ham-
psey, Robert Wood Johnson Medical School, New Jersey), fcp1-4
(Jack Greenblatt, University of Toronto), RPB1-epi2Fxa and Tfb3-
TAP (Roger Kornberg, Stanford University), and Ctk1-TAP (Open
Biosystems). Plasmids (sources) were: GST-Ssu72 (Mike Hampsey),
GST-Rsp5 (Jon Huibregtse, University of Texas at Austin) and GST-
Ubc5 (Ron Hay (University of St. Andrews).
Proteins
His-tagged ubiquitin, yeast GST-Uba1, and the human Ubc (E2)
proteins were purchased from Boston Biochemical. Def1 was puri-
fied as described (Reid and Svejstrup, 2004). GST-tagged proteins
(Rsp5, Ubc5, and Ssu72) were expressed in E. coli and purified on
glutathione Sepharose by standard techniques. Details are avail-
able on request.
RNAPII was purified using a two-step affinity purification pro-
cedure modified from (Edwards et al., 1990). Yeast extracts were
incubated in batch with 8WG16-conjugated Sepharose at 4°C for 4
hr to overnight. The resin was washed at 4°C and then at room
temperature, with 10 column volumes of buffer containing 50 mM
Tris-Cl (pH 7.5), 1 mM DTT, 1 mM EDTA, 10 M ZnCl2, 500 mM
(NH4)2SO4, and protease inhibitors. RNAPII was eluted at room
temperature with the same buffer but containing 50% (w/v) glyc-
erol. RNAPII was further purified by MonoQ HR5/5 chromatography
using an Åkta chromatography system (Amersham). The column
was equilibrated with 50 mM Tris-Cl (pH 7.5), 1 mM 2-mercapto-
ethanol, 200 mM KCl, 10% (w/v) glycerol, and protease inhibitors.
Fractions from 8WG16-Sepharose were diluted 5-fold in the same
buffer (without salt) prior to loading. The column was resolved with
a salt gradient (0.2–1 M KCl). RNAPII eluted at 0.6 M KCl.
For preparation of CTD-less RNAPII, the polymerase was purified
(from the strain RPB1-epi2FXa [Li and Kornberg, 1994]) on 8WG16-
Sepharose as described above. CTD-less RNAPII was released by
digestion with FXa protease (New England Biolabs) in 20 mM Tris-
Cl (pH 8.0), 175 mM NaCl, 2 mM CaCl2, 2 mM DTT for 6–12 hr
at 4°C.
The CTD kinases, TFIIK and CTDK1 were purified as described
(Rigaut et al., 1999) from yeast strains expressing TAP-tagged Tfb3
and Ctk1, respectively.
In Vitro Ubiquitylation and Mapping of an Rpb1
Ubiquitylation Site
For a typical in vitro ubiquitylation reaction, 300–450 ng RNAPII
was incubated with 40 ng rUba1, 40 ng rGST-Ubc5, 90 ng rGST-
Rsp5, 2 g rUbiquitin 2 mM ATP in ubiquitylation buffer (25 mM
Tris-Cl [pH 8.0], 125 mM NaCl, 2 mM MgCl2, 50 M DTT). Reactions
were incubated at 30°C for 90 min before adding SDS-PAGE load-
ing buffer. The samples were fractionated on a 4%–12% SDS-PAGE
gel (Bio-Rad) and blotted and probed with an anti-hexahistidine
antibody (Novagen). Anti-Rpb3 antibodies were from Neoclone.
Quantification was performed using a PhosphorImager (Molecular
Dynamics).
For mapping of RNAPII ubiquitylation sites, RNAPII ubiquitylated
in vitro using his-tagged ubiquitin was adsorbed to nickel agarose(Qiagen) and then fractionated by SDS-PAGE on a 6% gel. The gel-
fractionated Rpb1 protein was digested with trypsin and peptides
analyzed by matrix-assisted laser desorption/ionization reflectron
time-of-flight (MALDI-reTOF) MS as previously described (Winkler
et al., 2002).
Assembly of RNAPII Ternary Complexes
RNAPII ternary complexes were assembled from oligonucleotides,
essentially as described (Kireeva et al., 2000) (see also Figure S2).
Briefly, a biotinylated “coding strand” oligonucleotide (TS-1) was
annealed to a complementary RNA oligonucleotide (RNA-1) prior
to mixing with RNAPII. A 5-fold molar excess of DNA/RNA to
RNAPII was typically used. Then the nontranscribed strand (NTS-
1) oligonucleotide was added and the mixture incubated at 37°C
for 30 min prior to isolating ternary complexes (or DNA-RNAPII
complexes if RNA was omitted) via biotin-mediated binding to
magnetic streptavidin beads (Promega).
For comparison of a ternary complex and a ternary complex ar-
rested by a transcription-arresting DNA lesion, a single guanine ad-
duct was introduced at a specific site by treatment of the oligonu-
cleotide TS-1 with N-acetoxy-2-(acetylamino)fluorine (AAF) (Hansson
et al., 1989). The adduct-containing oligonucleotide was purified by
denaturing PAGE. The untreated and adduct-containing oligonu-
cleotides were then used with RNA oligonucleotide RNA-1 (which
places RNAPII 34 bases from the DNA lesion) or RNA-2 (which di-
rectly places RNAPII at the same position as achieved after tran-
scription to the DNA lesion when using RNA-1) and nontranscribed
oligonucleotide NTS-1 to assemble ternary complexes. When
RNA-1 was used, transcription (in the absence of CTP on undam-
aged DNA, but in its presence on damaged DNA) resulted in arrest
at the same site.
Sequences of oligonucleotides were as follows. TS-1: 5#-
CCCTTTCCTACCTACATACACCACACACCACACCGAG*CCCAACC
ACTTACCCCTTCACCTTTACCCTTACCCCTCTCCATACCACACCA
CCTTACCTACCACCCACCTTCCCTTACCCTTCCAX-3# (X = biotin;





RNAPII CTD Phosphorylation and Dephosphorylation
Three hundred nanograms of RNAPII was phosphorylated by TFIIK
(20–50 ng) or CTDK1 (20–50 ng), respectively, by incubation at 30°C
for 30 min in 40 mM HEPES-KOH (pH 7.5), 10 mM MgCl2, 5 mM
2-mercaptoethanol, 5% (w/v) glycerol, and 2 mM ATP. Similar re-
sults in ubiquitylation experiments were obtained whether or not
phosphorylated RNAPII was purified prior to use.
For dephosphorylation reactions, 300 ng phosphorylated RNAPII
was incubated with 2 g Ssu72 in 50 mM Tris-Cl (pH 7.9), 10 mM
MgCl2, 20 mM KCl, 5 mM DTT, 0.1 mM EDTA, 2% glycerol, 0.025%
Tween-20 and incubated at 30°C for 1–2 hr.
Immunoprecipitation of Ubiquitylated RNAPII
For testing the effect on ubiquitylation of transcriptional arrest, 250
g/ml 6-azauracil was added to yeast cells (made URA3 by trans-
formation with pRS316 if required), grown in minimal medium (SC,
−ura), 2.5 hr prior to preparing extracts. For testing the correlation
between ubiquitylation and phosphorylation, cells derived from a
strain surviving on myc/his-tagged ubiquitin (SUB592; Spence et
al., 2000) were irradiated with 300 J/m2 UV light to increase the
amount of ubiquitylated RNAPII prior to preparing extracts. Cells
were pelleted and resuspended in lysis buffer containing 150 mM
Tris-Cl [pH 7.5], 500 mM KOAc, 5 mM DTT, 3 mM EDTA, 20 M
lactocystine (Boston Biochemicals), 20% (w/v) glycerol, 2 mM
N-ethylmaleimide (Sigma), and protease inhibitors. Cells were dis-
rupted in a Hybaid Ribolyzer using glass beads according to the
manufacturer’s instructions. Disruption using glass beads shears
DNA so that elongating RNAPII is “solubilized,” but further shearing
was achieved by sonication of the extracts. After centrifugation,
the supernatant was mixed with 4H8 (anti-Rpb1 antibody) or 9E11
(anti-myc antibody) conjugated protein A-Sepharose to immuno-
precipitate RNAPII or ubiquitylated proteins, respectively. The pre-
Cell
922cipitated proteins were subjected to Western blotting, and blots f
2probed with anti-ubiquitin antibodies (6-AU experiment) (Stress-




Damage-induced RNAPII degradation in vivo was investigated as G
previously described (Woudstra et al., 2002). Irradiation was with (




Supplemental Data include five figures and are available with this
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